Telix Pharmaceuticals Forecast, price target & analysts
Telix Pharmaceuticals Target price 2025 - Analyst rating & recommendation
Telix Pharmaceuticals Classifications & Recommendation:
Telix Pharmaceuticals Price Target
| Target Price | AUD34.24 |
| Price | AUD26.68 |
| Potential |
28.34%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Telix Pharmaceuticals 2026 .
The average Telix Pharmaceuticals target price is AUD34.24.
This is
28.34%
register free of charge
AUD36.00
34.93%
register free of charge
AUD29.14
9.22%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Telix Pharmaceuticals to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Telix Pharmaceuticals stock has an average upside potential 2026 of
28.34%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million AUD | 783.21 | 1,277.81 |
| 55.85% | 63.15% | |
| EBITDA Margin | 11.52% | 14.86% |
| 0.96% | 29.03% | |
| Net Margin | 6.41% | 9.79% |
| 381.24% | 52.71% |
9 Analysts have issued a sales forecast Telix Pharmaceuticals 2025 . The average Telix Pharmaceuticals sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Telix Pharmaceuticals EBITDA forecast 2025. The average Telix Pharmaceuticals EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Telix Pharmaceuticals Analysts have issued a net profit forecast 2025. The average Telix Pharmaceuticals net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share AUD | 0.15 | 0.37 |
| 650.00% | 146.67% | |
| P/E | 76.39 | |
| EV/Sales | 7.45 |
6 Analysts have issued a Telix Pharmaceuticals forecast for earnings per share. The average Telix Pharmaceuticals EPS is
This results in the following potential growth metrics and future valuations:
Telix Pharmaceuticals...
Current Telix Pharmaceuticals Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| WILSONS |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| WILLIAM BLAIR & COMPANY |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| WILSONS |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Dec 29 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
WILSONS:
Locked
➜
Locked
|
Apr 07 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Mar 20 2025 |
|
Locked
WILLIAM BLAIR & COMPANY:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
WILSONS:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Dec 29 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
